Funding

BU CTSI Applications for Funding

Pilot Grant Programs
Other Funding Opportunities

Translational Technology Office (TTO) Online Core Subsidy Application   TOP

BU CTSI support for core lab use and mRNA or miRNA microarrays
February 21, 2014 DEADLINE *Please note that the deadline for this funding opportunity has passed. Please check back for future funding information.

The Boston University Clinical and Translational Science Institute’s Translational Technology Office has funding to support Boston University Investigators and Trainees who use Cores at BU.  The user’s protocols should already have IRB / IACUC and IBC approval.  The online Core Subsidy application can be found at http://wwwapp1.bumc.bu.edu/busm/csccs.  Please let your Core users know about this BU CTSI funding opportunity.  The deadline for online submission of this application will end at 5 PM on February 21, 2014.
Note: All laboratory work subsidized by this program must be completed by April 25, 2014.

Purpose of this RFA:
To support translational research through:

  1. subsidies to cover the cost of using BU core laboratory facilities and
  2. subsidies that cover most of the cost of human or mouse mRNA or miRNA microarrays in the BUMC Microarray Core Laboratory.

Who is eligible to apply:
Full-time BU faculty. (Graduate students or post-doctoral fellows should apply under the sponsorship of their full-time BU faculty mentor.)

Only projects that have all necessary IRB, IACUC, and IBC approvals already completed are eligible (approval numbers and expirations dates required in the application).

Support available:

  1. Core Laboratory Vouchers: This support may be used to subsidize research done in any BUMC or BUCRC core laboratory (CTSI/Resources/Cores). We are not stating a maximum amount that may be applied for, but it is anticipated that awards will not exceed $3,000 to an investigator.
  2. Subsidies for microarrays: These will cover most of the cost of mRNA or miRNA microarray laboratory supplies and processing, along with basic gene-level data analysis, in the BUMC Microarray Core Laboratory (Director, Yuriy Alekseyev, PhD). (For more complex analyses, the Translational Bioinformatics consulting service of BU CTSI may be able to assist with bioinformatic analysis.) For projects that are chosen for support, BU CTSI will cover material and processing costs except $100 per array, which must be paid by the investigator. (Note: It is expected that RNA extraction from samples will be done by the investigator, and the cost of this is not covered.) Arrays may include the Affymetrix Human Gene 1.0 or 2.0 St Array; the Affymetric Mouse Gene 1.0 or 2.0 St Array; or the Affymetric microRNA Array. The maximum number of arrays that will be subsidized is 24 per investigator.

Because all laboratory work subsidized by this program must be completed by April 25, 2014, investigators should only apply for support if their research timeline is such that the core laboratory use or delivery of RNA specimens to the Microarray Core Laboratory can take place within this time frame.

How to apply
Please complete the online application at http://wwwapp1.bumc.bu.edu/busm/csccs.

Please note that a required field that must be completed is “What is the account authorized to use the Core Scheduler? Either BUSM Internal Order or BMC AU Number. If core account does not appear in list, then please go to http://wwwapp.bumc.bu.edu/BUSM/CoreDevices. You will need to establish a core user account at the latter website (if you do not already have one) before you can submit an application.

To request support for microarrays, choose “Microarray Core” from the drop-down menu under “Core Type Service Requested.” For “Amount ($) requested,” enter the number of arrays requested and choose “units” on the following line.

Review process and review criteria:
Applications will be reviewed by the leadership of BU CTSI, and decisions whether to support a request will take into consideration:

  • Significance of the work in terms of potential for translation and impact on disease prevention, diagnosis, or treatment
  • Scientific rigor and novelty of the proposed approach
  • Likelihood that the project will lead to subsequent external funding and/or commercial development

Progress reports:
By accepting this support, the applicant agrees to submit a brief progress report to BU CTSI indicating key results and any publications, grant applications, grants, or intellectual property that resulted from the project. This brief progress report will be due approximately one year after completion of the funded work is conducted. The applicant also agrees to cite BU CTSI support in resultant publications.

Contacts:
For questions regarding this RFA, please contact Tai C. Chen, PhD (taichen@bu.edu) or George T. O’Connor, M.D., M.S. (goconnor@bu.edu).

You will be notified of funding by Dr. Tai C. Chen via e-mail.  All work must be completed by April 25, 2014.

Also please acknowledge CTSI support by citing our CTSI NIH grant number UL1-TR000157 in relevant publications.

BU Integrated Biomedical Pilot Grants Program    TOP

April 15, 2012 DEADLINE *Please note that the deadline for this funding opportunity has passed. Please check back for future funding information.   TOP

The BU CTSI is now accepting applications for translational research pilot grants as part of the BU Integrated Biomedical Pilot Grants Program. The deadline for online submission of proposals is Sunday, April 15, 2012 at midnight.

The purpose of the program is to fund innovative research at Boston University, integrating the application and review process of a number pilot grant programs at Boston University:

  • BU Clinical and Translational Science Institute (BU CTSI)
  • Department of Medicine– including Obesity (co-funding with Boston Nutrition Obesity Research Center)
  • Center for Nanoscience and Nanobiotechnology
  • Department of Biomedical Engineering – Coulter Translational Partnership
  • High-Throughput Screening Core

Direct costs may be requested as follows:

  • Pilot grants not involving human subject recruitment or data collection: Up to $15,000
  • Pilot grants involving human subjects: Up to $25,000
  • Pilot grant involving nanotechnology for targeted drug delivery (co-funded by Center for Nanoscience and Nanobiotechnology and BU CTSI): Up to $25,000
  • High-Throughput Screening Core pilot projects: These awards involve the provision of services and resources of the BU’s High-Throughput Screening Core, as described above, to help the applicant develop a high-throughput screening assay. (No direct funding is provided to the investigator, so no budget is required if applying for this category only.)

Details about the BU Integrated Biomedical Pilot Grants Program, including eligibility, scope of research, funds available, how to apply and application are available here.   TOP